Features of innate immunity indicators in patients with recurrent exudative otitis media

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Kryukov A.I.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-0149-0676

Gankovskaya L.V.

Russian National Research Medical University named after N.I. Pirogov

Bondareva G.P.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Kunelskaya N.L.

L. I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-1001-2609

Garov E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0003-2473-3113

Nasaeva E.D.

Pirogov Russian National Research Medical University

Martirosyan T.G.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology of the Moscow Healthcare Department

Features of innate immunity indicators in patients with recurrent exudative otitis media

Authors:

Kryukov A.I., Gankovskaya L.V., Bondareva G.P., Kunelskaya N.L., Garov E.V., Nasaeva E.D., Martirosyan T.G.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2023;88(1): 4‑9

DOI: 10.17116/otorino2022880114

Views: 900

Downloaded: 38

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kryukov AI, Gankovskaya LV, Bondareva GP, Kunelskaya NL, Garov EV, Nasaeva ED, Martirosyan TG. Features of innate immunity indicators in patients with recurrent exudative otitis media. Russian Bulletin of Otorhinolaryngology. 2023;88(1):4‑9. (In Russ.)
https://doi.org/10.17116/otorino2022880114

Подписка 2025 (Russian Bulletin of Otorhinolaryngology)

Использование инфографики авторами научных работ

Mediasphera_Net

Close metadata

The article presents the features of the indicators of the innate immune response (TLR4, IL1B, TGFB, HBD1, and HBD2) in the exudate of the tympanic cavity in patients with recurrent exudative otitis media (EOM) with normal patency of the auditory tube and its dysfunction. The results of the study demonstrate changes in the indices of the innate immune response characteristic of the inflammatory process in patients with recurrent EOM against the background of dysfunction of the auditory tube in comparison with the group where it is absent. The data obtained can be used to clarify the pathogenesis of otitis media with dysfunction of the auditory tube, to develop new methods of diagnosis, prevention and therapy.

Keywords:

recurrent exudative otitis media

congenital immune response

Authors:

Kryukov A.I.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-0149-0676

Gankovskaya L.V.

Russian National Research Medical University named after N.I. Pirogov

Bondareva G.P.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Kunelskaya N.L.

L. I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-1001-2609

Garov E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0003-2473-3113

Nasaeva E.D.

Pirogov Russian National Research Medical University

Martirosyan T.G.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology of the Moscow Healthcare Department

Received:

28.10.2022

Accepted:

13.12.2022

List of references:

Williamson I. Otitis media with effusion. Clinical Evidence. 2002; 7:469-476.
Preobrazhensky NA, Goldman II. Ekssudativnyj srednij otit. M.: Meditsina; 1987. (In Russ.).
Arefieva NA, Stratieva OV, Salakhova GM, Khafizova FA, Dragunskaya MI, Sharipov RA, Zhiyanbaeva M, Smakaeva DF. Choice of tactics of conservative treatment of otitis media with effusion. Vestnik otorinolaringologii. 1998;2:24-27. (In Russ.).
Arbesman CE. Secretory otitis media. A review. Acta Otorhinolaryngologica Belgica. 1979;33(4):464-473.
Alper C, Winther B, Mandel E, Doyle W. Temporal relationships for cold-like illnesses and otitis media in sibling pairs. The Pediatric Infectious Disease Journal. 2007;26(9):778-781. https://doi.org/10.1097/INF.0b013e318124aa31
Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A. HMGB1: endogenous danger signaling. Molecular Medicine. 2008;14(7-8): 476-484. https://doi.org/10.2119/2008-00034
Leichtle A, Lai Y, Wollenberg B, Wasserman S, Ryan A. Innate signaling in otitis media: pathogenesis and recovery. Current Allergy and Asthma Reports. 2011;11(1):78-84. https://doi.org/10.1007/s11882-010-0158-3
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nature Immunology. 2010;11(5):373-384. https://doi.org/10.1038/ni.1863
Naiki Y, Michelsen KS, Zhang W, Chen S, Doherty TM, Arditi M. Transforming growth factor-β differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. The Journal of Biological Chemistry. 2005;280(7):5491-5495. https://doi.org/10.1074/jbc.C400503200
Libby P. Interleukin-1 Beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond. Journal of the American College of Cardiology. 2017;70(18):2278-2289. https://doi.org/10.1016/j.jacc.2017.09.028
Woodfin A, Voisin MB, Imhof BA, Dejana E, Engelhardt B, Nourshargh S. Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1. Blood. 2009(24);113:6246-6257. https://doi.org/10.1182/blood-2008-11-188375
Thomas G, Tacke R, Hedrick CC, Hanna RN. Nonclassical patrolling monocyte function in the vasculature. Arteriosclerosis, Thrombosis, and Vascular Biology. 2015;35(6):1306-1316. https://doi.org/10.1161/ATVBAHA.114.304650
Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annual Review of Immunology. 2006;24:99-146. https://doi.org/10.1146/annurev.immunol.24.021605.090737
Belladonna ML, Volpi C, Bianchi R, Vacca C, Orabona C, Pallotta MT, Boon L, Gizzi S, Fioretti MC, Grohmann U, Puccetti P. Cutting edge: autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. Journal of Immunology. 2008;181(8):5194-5198. https://doi.org/10.4049/jimmunol.181.8.5194
Werner F, Jain MK, Feinberg MW, Sibinga NE, Pellacani A, Wiesel P, Chin MT, Topper JN, Perrella MA, Lee ME. Transforming growth factor-β1 inhibition of macrophageactivationismediatedvia Smad3. The Journal of Biological Chemistry. 2000; 275(47):36653-36658. https://doi.org/10.1074/jbc.M004536200
Cooter M, Eisma R, Burleson J, Leonard G, Lafreniere D, Kreutzer D. Transforming growth factor-β expression in otitis media with effusion. Laryngoscope. 1998;108(7):1066-1070.
Melhus A, Ryan A. Expression of cytokine genes during pneumococcal and non-typeable Haemophilus influenzae acute otitis media in the rat. Infection and Immunity. 2000;68(7):4024-4031. PMID: 10858218; PMCID: PMC101687. https://doi.org/10.1128/IAI.68.7.4024-4031.2000
Melhus A. Effects of amoxicillin on the expression of cytokines during experimental acute otitis media caused by nontypeable Haemophilus influenzae. The Journal of Antimicrobial Chemotherapy. 2001;48(3):397-402. https://doi.org/10.1093/jac/48.3.397
Lin J, Tsuprun V, Kawano H, Paparella MM, Zhang Z, Anway R, Ho SB. Characterization of mucins in human middle ear and Eustachian tube. American Journal of Physiology. Lung Cellular and Molecular Physiology. 2001;280(6):1157-1167. https://doi.org/10.1152/ajplung.2001.280.6.L1157
Letterio J, Roberts A. Regulation of immune responses by TGF-beta. Annual Review of Immunology. 1998;16:137-161. https://doi.org/10.1146/annurev.immunol.16.1.137
Defrance T, Vanbervliet B, Brière F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. The Journal of Experimental Medicine. 1992;175(3):671-682. https://doi.org/10.1084/jem.175.3.671
Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G, Oppenheim JJ. Defensin participation in innate and adaptive immunity. Current Pharmaceutical Design. 2007;13(30):3131-3139. https://doi.org/10.2174/138161207782110453
Prado-Montes de Oca E. Human beta-defensin 1: A restless warrior against allergies, infections and cancer. The International Journal of Biochemistry and Cell Biology. 2010;42(6):800-804. https://doi.org/10.1016/j.biocel.2010.01.021
Moon SK, Lee HY, Li JD, Nagura M, Kang SH, Chun YM, Linthicum FH, Ganz T, Andalibi A, Lim DJ. Activation of a Src-dependent Raf-MEK1/2-ERK signalingpathwayisrequired for IL-1alpha-induced upregulation of beta-defensin 2 in humanmiddleearepithelialcells. Biochimica et Biophysica Acta. 2002;1590(1-3): 41-51. https://doi.org/10.1016/s0167-4889(02)00196-9

Close metadata

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.